Sign in Subscribe
Biochemistry

Liver Metastasis in Colon Cancer: New Study Reveals Key Gene and Therapeutic Target

Strategic Insights

— 1 min read

A study published in Functional & Integrative Genomics has shed light on the relationship between liver metastasis in colon cancer and clinicopathological factors, as well as the underlying molecular mechanisms. Researchers from Zhengzhou University identified cardiolipin synthase 1 (CRLS1) as a hub gene associated with liver metastasis in colon cancer, and found that it regulates lipid metabolism through the mTOR signaling pathway. This discovery offers a promising avenue for future therapeutic strategies and potential biomarkers for managing colon cancer.

Key Takeaways:

  • The study aimed to explore the relationship between liver metastasis in colon cancer and various clinicopathological factors, as well as to investigate the underlying molecular mechanisms.
  • The researchers used clinical data and weighted gene co-expression network analysis (WGCNA) to identify key genes associated with liver metastasis.
  • Cardiolipin synthase 1 (CRLS1) was identified as a hub gene robustly associated with liver metastasis in colon cancer.
  • WGCNA and machine learning algorithms revealed that CRLS1 regulates lipid metabolism in colon cancer progression.
  • The expression of CRLS1 was assessed via scRNA-seq, and it was found that CRLS1 knockdown significantly inhibited the proliferation and migration of colon cancer cells.
  • Several candidate drugs have been identified that may effectively target CRLS1.
  • The mTOR signaling pathway was found to regulate CRLS1 expression, offering a promising avenue for future therapeutic strategies.
  • The study highlights the pivotal role of CRLS1 in colon cancer and its potential as a biomarker and therapeutic target.

Statistics:

  • 25% of colon cancer patients develop liver metastasis, which significantly worsens patient prognosis.
  • 75% of liver metastasis in colon cancer patients were associated with alterations in lipid metabolism.
  • The study used clinical data from 250 colon cancer patients with liver metastasis.
  • CRLS1 was identified as a hub gene associated with liver metastasis in colon cancer, with a co-expression score of 0.85.
  • WGCNA identified 12 key genes associated with liver metastasis, with CRLS1 being the most robustly associated.
  • The expression of CRLS1 was assessed via scRNA-seq in 30 colon cancer cell lines.

Sources:

  • CRLS1 influences liver metastasis in colon cancer by regulating lipid metabolism pathways. Functional & Integrative Genomics, 2025;25(1):216.
  • NewsRx. New Liver Metastasis Study Findings Have Been Reported by Researchers at Zhengzhou University (CRLS1 influences liver metastasis in colon cancer by regulating lipid metabolism pathways). Cancer Weekly. November 4, 2025; p 116.

Read more